Jochen Sven Utikal
German Cancer Research Center
Affiliation German Cancer Research Center Top Publications Genomic correlates of response to CTLA-4 blockade in metastatic melanoma (2015) – 3,031 citations Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer (2017) – 2,545 citations Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma (2012) – 2,192 citations Combined BRAF and MEK Inhibition versus BRAF Inhibition ... <a title="Jochen Sven Utikal" class="read-more" href="https://journalsworld.com/researchers/jochen-sven-utikal/" aria-label="Read more about Jochen Sven Utikal">Read more</a>
Read biography ↓Biography, research & contributions
Affiliation
German Cancer Research Center
Top Publications
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma (2015) - 3,031 citations
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer (2017) - 2,545 citations
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma (2012) - 2,192 citations
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma (2014) - 1,927 citations
- Directly Reprogrammed Fibroblasts Show Global Epigenetic Remodeling and Widespread Tissue Contribution (2007) - 1,751 citations
At a glance
- Full name
- Jochen Sven Utikal
- ORCID
- 0000-0001-5316-0241
- OpenAlex ID
- https://openalex.org/A5007887862
Research interests
- Cutaneous Melanoma Detection and Management, Cancer Immunotherapy and Biomarkers, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses, Immune cells in cancer
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-08. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- 3,031OpenAlex citations
- 2,545OpenAlex citations
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma ↗2012 · New England Journal of Medicine2,192OpenAlex citations
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma ↗2014 · New England Journal of Medicine1,927OpenAlex citations
- 1,751OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma ↗2012 · New England Journal of Medicine
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma ↗2014 · New England Journal of Medicine
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-08 · Last data update: 2026-10-08 00:45:10
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.